Last reviewed · How we verify

NCT04395885

Sexual Function During COVID 19 Pandemic

Completed Last updated 6 October 2020
What this trial tests

trial testing Electronic questionnaire in Sexual Dysfunction in 306 participants. Completed in 15 September 2020.

Timeline
1 June 2020
Primary endpoint
31 August 2020
15 September 2020

Quick facts

Lead sponsorAssiut University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment306
Start date1 June 2020
Primary completion31 August 2020
Estimated completion15 September 2020
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 40, any sex, with Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The outbreak of a new Coronavirus disease (COVID-19), caused by the 2019-nCoV infection in December 2019 is one of the most severe global epidemic health problems.The rapid contagion of this Novel virus has provoked the World Health Organization (WHO) to classifying the outbreak as a "Public Health Emergency of International Concern" on January 30 2020 to a "Pandemic" on March 11th 2020

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Electronic questionnaire

Trials testing the same drug.

Other recruiting trials for Sexual Dysfunction

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04395885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing